Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Genetic Technologies Sponsored ADR Representing 30 Ord Shs GENE

Technology Scientific & Technical Instruments
Genetic Technologies Limited is an Australia-based diversified molecular diagnostics company. The Company is engaged in providing genomics-based tests on health, wellness and serious disease through its geneType and EasyDNA brands. The Company offers cancer predictive testing and assessment tools to help physicians to improve health outcomes for people around the world. The Company has a... see more

Recent & Breaking News (NDAQ:GENE)

Genetic Technologies drives leadership in precision medicine with Multi-Risk Test

GlobeNewswire April 8, 2022

US Patent Office Grants Patent for COVID-19 Risk Test

GlobeNewswire February 23, 2022

GeneType Multi-Test Receives Regulatory Approval for Commercial Release in USA and Australia

GlobeNewswire February 22, 2022

Genetic Technologies Reports Q2 FY22 Cash Flow Results

GlobeNewswire January 19, 2022

Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, 'Company', 'GENE', 'geneType'), a global leader in genomics-based tests in health, wellness and serious disease provides the following business update:

GlobeNewswire December 21, 2021

GENE Presents Study Involving 200,000 Participants at 2021 San Antonio Breast Cancer Symposium

GlobeNewswire December 10, 2021

Genetic Technologies Announces New Partnership and geneType COVID-19 Risk Test Patent Allowance from the USPTO

GlobeNewswire December 9, 2021

Genetic Technologies Reports Q1 FY22 Results

GlobeNewswire October 25, 2021

GENE Delivers Material 12-Fold Increase in Revenue in the Quarter Ended September 2021

GlobeNewswire October 4, 2021

Genetic Technologies Limited Interview to Air on Bloomberg TV (U.S.) on the RedChip Money Report®

GlobeNewswire September 30, 2021

GENE Embarks on Breakthrough African American Collaboration for Breast Cancer as Part of Its Commitment to Ethnic Diversity

GlobeNewswire September 28, 2021

BelHealth Completes Asset Sale of General Genetics Corp.

PR Newswire September 9, 2021

Genetic Technologies Reports FY21 Results as it Turns the Corner on its Commercialization Strategy

GlobeNewswire August 31, 2021

Genetic Technologies Enters Multi-Billion-Dollar Consumer Genomics Market

GlobeNewswire August 16, 2021

Genetic Technologies Rapidly Accelerating Commercialization Plans

GlobeNewswire July 26, 2021

Genetic Technologies Strengthens Global Leadership in Genomics with Acquisition of EasyDNA

GlobeNewswire July 19, 2021

Genetic Technologies Continues to Break New Ground as it Advances Development of its Predictive Risk Test for Multiple Cancers & Morbidities

GlobeNewswire July 9, 2021

US Patent Office Grants Foundational Pharmacogenomic Patent

GlobeNewswire June 11, 2021

Genetic Technologies' COVID-19 Risk Test Now Available in US through Partnership with Infinity BiologiX

GlobeNewswire June 1, 2021

Genetic Technologies Interview to Air on Bloomberg Television U.S. on the RedChip Money Report®

GlobeNewswire May 13, 2021